| __timestamp | Bausch Health Companies Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 246000000 | 1488000000 |
| Thursday, January 1, 2015 | 582800000 | 1525000000 |
| Friday, January 1, 2016 | 455000000 | 2111000000 |
| Sunday, January 1, 2017 | 366000000 | 1848000000 |
| Monday, January 1, 2018 | 414000000 | 1213000000 |
| Tuesday, January 1, 2019 | 471000000 | 1010000000 |
| Wednesday, January 1, 2020 | 452000000 | 997000000 |
| Friday, January 1, 2021 | 465000000 | 967000000 |
| Saturday, January 1, 2022 | 529000000 | 838000000 |
| Sunday, January 1, 2023 | 604000000 | 953000000 |
| Monday, January 1, 2024 | 998000000 |
Data in motion
In the ever-evolving pharmaceutical industry, research and development (R&D) is the lifeblood of innovation. Over the past decade, Teva Pharmaceutical Industries Limited and Bausch Health Companies Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Teva consistently outpaced Bausch, investing nearly three times more on average. Notably, in 2016, Teva's R&D expenses peaked, reaching over twice the amount of Bausch's highest investment year. However, Bausch has shown a steady increase, culminating in a 145% rise from 2014 to 2023. This trend highlights Bausch's growing commitment to innovation, while Teva's fluctuating investments suggest a strategic recalibration. As the pharmaceutical landscape continues to shift, these investment patterns may offer insights into each company's future growth and innovation potential.
Analyzing R&D Budgets: Bristol-Myers Squibb Company vs Teva Pharmaceutical Industries Limited
Research and Development: Comparing Key Metrics for argenx SE and Bausch Health Companies Inc.
Research and Development Expenses Breakdown: Teva Pharmaceutical Industries Limited vs Dr. Reddy's Laboratories Limited
R&D Insights: How Teva Pharmaceutical Industries Limited and Ascendis Pharma A/S Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Halozyme Therapeutics, Inc.
Who Generates More Revenue? Teva Pharmaceutical Industries Limited or Bausch Health Companies Inc.
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Agios Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Bausch Health Companies Inc.
Analyzing R&D Budgets: Veracyte, Inc. vs Bausch Health Companies Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Bausch Health Companies Inc. Allocate Funds
Research and Development Expenses Breakdown: Bausch Health Companies Inc. vs Mesoblast Limited
Analyzing R&D Budgets: Bausch Health Companies Inc. vs Ligand Pharmaceuticals Incorporated